Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Jul 11, 2014

NEW YORK (GenomeWeb) – Mark Guyer has retired from his post as deputy director of the National Human Genome Research Institute, NHGRI said last week.

Guyer has worn many hats at NHGRI since he joined the Office of Human Genome Research, the institute's precursor, in 1998, and he helped guide NHGRI's research activities from the earliest days of the Human Genome Project. He contributed to "making the various parts of the HGP come together as a working project," NHGRI said, and helped NHGRI come together as an organization. Although he was not the architect of the HGP, he played an "indispensable" role in so many aspects of the project, NIH Director Francis Collins said.

In 2002, Guyer became director of the NHGRI Division of Extramural Research, now the Extramural Research Program, and he has had a hand in establishing programs such as the 1,000 Genomes Project; the Large-Scale Genome Sequencing and Analysis Centers; the Ethical, Legal and Social Implications research program; and The Cancer Genome Atlas project, among others.

Although he officially retired on June 30, Guyer will continue to work at NHGRI on a part-time basis on the H3Africa Program and the Big Data to Knowledge initiative.


Gary Kruppa has joined MRM Proteomics, a University of Victoria spinoff, as its president and CEO, Genome BC said this week. Kruppa formerly was VP of business development for Bruker Daltonics.

Genome BC also said Christoph Borchers, MMRP's chief scientific officer and director of the UVic-Genome BC Proteomics Centre, has been jointly appointed as the proteomics chair for the Jewish General Hospital at McGill University.


Strand Life Sciences has named Scott Storrer to be president of its North America operations. Storrer most recently was president and CEO of Genomind, and before that he was president and CEO of MEDicision and chief operations officer for CIGNA's healthcare, group insurance, and international divisions.


Ellen Embrey has joined Pathway Genomics' strategic advisory board. Embrey currently is CEO of Stratitia, a medical logistics and scientific consulting company. She also previously worked at the Department of Defense, including as assistant secretary of defense for health affairs and director of TRICARE management activity and as deputy assistant secretary of defense for force health protection readiness.


Paul Menter has joined SomaLogic as VP and general manager of Life Science Tools. In the role he will be responsible for overseeing growth of the firm's current proteomics tools and expanding its offerings to life science researchers.

Menter recently was GM of Bioseparations at Thermo Fisher Scientific and at Dionex, and before that he was division manager of lab separations and of North American Sales and Service at Bio-Rad Laboratories.


Provista Diagnostics, a developer of proteomics-based cancer tests, has appointed Rao Mulpuri to the post of COO. Most recently Mulpuri was VP of lab operations for Assurex Health, and he has held various leadership positions at Catholic Health Initiatives Center for Translational Research, Beckman Coulter Genomics, and Cogenics.


Joseph Haywood is now president of The Federation of American Societies for Experimental Biology. A professor of pharmacology and toxicology and assistant VP for regulatory affairs at Michigan State University, Haywood served as FASEB's VP for Science Policy and has chaired two of the group's committees. He is a member of the American Physiological Society and the American Society for Pharmacology and Experimental Therapeutics.


Proteome Sciences has named Roger McDowell to its board as a non-executive director.

McDowell was previously managing director of pipeline firm Oliver Ashworth and currently sits on the boards of various listed companies.


Gonçalo Abecasis and Mark Daly have been named recipients of the Curt Stern Award from the American Society of Human Genetics.

Abecasis is a professor of biostatistics at the University of Michigan School of Public Health, and Daly is an associate professor of medicine and chief of the analytic and translational genetics unit at Massachusetts General Hospital and Harvard Medical School.

The award recognizes genetics and genomics researchers who have made significant scientific contributions during the past decade. Abecasis and Daly will receive the award, which carries a $5,000 cash prize for each, on Oct. 20 at the ASHG Annual Meeting in San Diego.


Promoted? Changing jobs? GenomeWeb wants to know. [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.